Schrödinger Highlights Progress of Clinical Programs an

14.12.2023 - Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, is providing a detailed review of its proprietary drug discovery and development programs during its Pipeline ... Seite 1

Related Keywords

United States , American , Margaret Dugan , American Society Of Hematology Annual Meeting , Pipeline Day , American Society , Hematology Annual , Schrodinger Chart , Chrodinger Kurs , Chrodinger Aktie ,